Hepatectomy for Early-stage HCC Patients With CSPH

Clinically Significant Portal Hypertension (CSPH) on Early-stage HCC Following Hepatectomy: What's the Impact?

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05402644

Enrollment

320

Registered

2022-06-02

Start date

2009-12-01

Completion date

2022-01-01

Last updated

2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC, Portal Hypertension

Brief summary

Clinically significant portal hypertension (CSPH) can affect the surgical prognosis of early-stage (BCLC stage A) HCC. An additional stage, such as the BCLC stage A-B, can be considered.

Interventions

PROCEDUREhepatectomy

Liver resection

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

HCC was diagnosed by two experienced pathologists in Child-Pugh grade A/B negative resection margin Initial diagnosis of HCC in the patients

Exclusion criteria

Distant transfer Not HCC

Design outcomes

Primary

Measure	Time frame	Description
death	2009--2025	Patient survival time after surgery
recurrence	2009--2025	Patient recurrence time after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026